Current Study: A2

Study: A2

Research Study:


• The overall purpose for this study is to find out if the study drug is absorbed or eliminated differently in subjects with normal liver function compared to subjects with impaired liver function. Another purpose is to assess the safety and tolerability of the study drug in people with healthy to impaired liver function.
• This study is for research purposes only and is not intended to treat your liver disease.

Method of Administration:
Single oral dose of study drug

Investigator: Thomas Marbury, MD

To qualify:

• 18 years to 80 years old
• Must have decreased liver function or disease such as fatty liver disease (NASH), Hepatitis C, past history of alcohol related liver disease or cirrhosis.
• Volunteers may be taking certain medicines and still be able to participate, however, you will need to check with the study staff if any of your medications are not allowed.
• May also have ascites (fluid in your abdomen) or encephalopathy (brain condition that causes irritability or trouble sleeping).

• 1 eligibility screening visit
• 8 days and 7 nights in our research facility

Location 5055 South Orange Avenue, Orlando, FL 32809

Qualified participants will receive study medication, study related physical exams and laboratory tests.. This is not a complete list of the benefits to participation. Speak to a member of the research study team to learn more.

Compensation Compensation up to $2,550 is available to qualified participants for time and travel

Whom to Contact Recruitment Department: 407-240-7876


Orlando Clinical Research Center
5055 South Orange Avenue
Orlando, FL 32809

Recruiting Number: 407.240.7878

Apply now for Study: A2